Month: June 2021

CTF Chief Scientific Advisor Shares Critical Analysis of FDA’s New Approved Alzheimer’s Drug, Aducanumab.

Clear Thoughts | June 8, 2021

Clear Thoughts Foundation’s Chief Scientific Advisor, Dr. Karl Herrup, offers his critical analysis of the FDA’s decision to approve new Alzheimer’s drug, Aducanumab.…

Read more

CTF Featured in PITT MED Magazine (Spring 2021)

Clear Thoughts | June 1, 2021

University of Pittsburgh School of Medicine, PITT MED Magazine Spring 2021 edition, features the work of the CTF Consortium funded by CTF.…

Read more
Top